77.84

0.46% -0.36

Bright Minds Biosciences Inc (DRUG)

Overview News Price History Discussions Forecast Stock Split

Bright Minds Biosciences Inc stock is traded at $77.84, with a volume of 331.43K. It is down -0.46% in the last 24 hours and up +26.45% over the past month. Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Previous Close:

$78.20

Open:

$77.42

24h Volume:

331.43K

Relative Volume:

1.13

Market Cap:

$763.77M

Revenue:

Net Income/Loss:

$-19.80M

P/E Ratio:

-31.87

EPS:

-2.4426

Net Cash Flow:

$-14.56M

1W Performance:

+15.15%

1M Performance:

+26.45%

6M Performance:

-10.27%

1Y Performance:

+200.19%

1-Day Range:

$71.22

$78.27

1-Week Range:

$63.44

$78.85

52-Week Range:

$24.00

$123.75

Bright Minds Biosciences Inc Stock (DRUG) Company Profile

Name

Bright Minds Biosciences Inc

Sector

Healthcare (1096)

Industry

Biotechnology (616)

Phone

Address

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

DRUG's Discussions on Twitter

Compare DRUG vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DRUG Bright Minds Biosciences Inc	77.84	763.77M	0	-19.80M	-14.56M	-2.4426
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-13-26	Initiated	Jefferies	Buy
Sep-08-25	Initiated	BTIG Research	Buy
May-13-25	Initiated	TD Cowen	Buy
May-07-25	Initiated	Chardan Capital Markets	Buy
Jan-23-25	Initiated	Piper Sandler	Overweight
Jan-10-25	Initiated	Cantor Fitzgerald	Overweight
Jan-10-25	Initiated	H.C. Wainwright	Buy
Nov-26-24	Initiated	Robert W. Baird	Outperform

View All

Bright Minds Biosciences Inc Stock (DRUG) Latest News

Jul 10, 2026

Bright Minds Biosciences (NASDAQ:DRUG) Shares Down 7.7%What's Next? - MarketBeat

Jul 10, 2026

Jul 08, 2026

Bright Minds Biosciences Inc Company Profile & Introduction - Moomoo

Jul 08, 2026

Jul 03, 2026

Form 13D/A BRIGHT MINDS BIOSCIENCES INC. For: 2 July By Investing.com - Investing.com Canada

Jul 03, 2026

Jul 02, 2026

Canadian Securities Exchange Reports January 2026 Performance Figures - The Canadian Securities Exchange (CSE)

Jul 01, 2026

Jun 29, 2026

Indivior Pharmaceuticals Inc. (INDV) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance

Jun 29, 2026

BrightSpring Health Services, Inc. (BTSG) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance

Jun 29, 2026

Jun 28, 2026